BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18562238)

  • 1. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
    Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
    Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
    Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
    Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
    Holmberg B; Johnels B; Blennow K; Rosengren L
    Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes.
    Süssmuth SD; Uttner I; Landwehrmeyer B; Pinkhardt EH; Brettschneider J; Petzold A; Kramer B; Schulz JB; Palm C; Otto M; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2010 Jul; 25(9):1284-8. PubMed ID: 20589870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.
    Verbeek MM; De Jong D; Kremer HP
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):25-40. PubMed ID: 12542908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F; Ding J; Liu Y; Lin H; Chang T
    Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical biomarkers in the differential diagnosis of movement disorders.
    Mollenhauer B; Trenkwalder C
    Mov Disord; 2009 Jul; 24(10):1411-26. PubMed ID: 19412961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities.
    Kristjánsdóttir R; Uvebrant P; Rosengren L
    Neuropediatrics; 2001 Dec; 32(6):307-12. PubMed ID: 11870586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
    Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
    Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.
    Michotte A
    Acta Neurol Belg; 2003 Sep; 103(3):155-8. PubMed ID: 14626695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.